Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Marseille
SEC filing record 1 source field available
Fiscal year end
31 December
Innate Pharma SA has filed 337 SEC EDGAR filings since 31 Jan 2014

SEC filing history

Showing 51-75 of 337 matching filings.

Per page
25
Current page
3
6-K File 001-39084

6-K

Filing date
17 Jun 2025
Reporting date
17 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
13 Jun 2025
Reporting date
13 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39084

144 filing

Filing date
30 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
27 May 2025
Reporting date
27 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
23 May 2025
Reporting date
23 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
23 May 2025
Reporting date
23 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
19 May 2025
Reporting date
19 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
15 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
13 May 2025
Reporting date
13 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
12 May 2025
Reporting date
12 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91173

SCHEDULE 13D/A filing

Filing date
07 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
06 May 2025
Reporting date
06 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
30 Apr 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91173

SCHEDULE 13G/A filing

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
29 Apr 2025
Reporting date
29 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91173

SCHEDULE 13G filing

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
28 Apr 2025
Reporting date
28 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
24 Apr 2025
Reporting date
24 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
23 Apr 2025
Reporting date
23 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
16 Apr 2025
Reporting date
16 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
16 Apr 2025
Reporting date
16 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
03 Apr 2025
Reporting date
03 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
27 Mar 2025
Reporting date
27 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
26 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .